Hibaoui et al. found that treatment with EGCG, an inhibitor of DYRK1A kinase activity or shRNA against DYRK1A before starting neural induction of hiPSCs rescued DS neural differentiation (Hibaoui et al., 2014). The gene discussed is DYRK1A; the disease is Dravet syndrome.